Marios Stavrakas

Dr. Marios Stavrakas

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2016 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
MSMarios Stavrakas
Marios Stavrakas
PKP D Karkos
P D Karkos
KMK Markou
K Markou
NGN Grigoriadis
N Grigoriadis
Background: Platelet-rich plasma is a novel material that is being used more frequently in many surgical specialties.Methods: A literature review on the current and potential uses of platelet-rich plasma in otolaryngology was performed.Results: There is limited evidence on the use of platelet-rich plasma in otolaryngology compared with other specialties: only 11 studies on various subspecialties (otology, rhinology and laryngology) were included in the final review.Conclusion: Based on the limited number of studies, we cannot draw safe conclusions about the value of platelet-rich plasma in otolaryngology. Nevertheless, the available literature suggests that platelet-rich plasma holds promise for future research and may have a number of clinical applications.

1 August 2016 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
MSMarios Stavrakas
Marios Stavrakas
INIain Nixon
Iain Nixon
KAK Andi
K Andi
ROR Oakley
R Oakley
JJJ P Jeannon
J P Jeannon
RSR Simo
R Simo
Background: Sarcoma of the head and neck is a rare condition that poses significant challenges in management and often requires radical multimodality treatment.Objectives: This study aimed to analyse current clinical presentation, evaluation, management dilemmas and oncological outcomes.Methods: Computer records and case notes were analysed, and 39 patients were identified. Variables were compared using Pearson's chi-square test and the log-rank test, while survival outcomes were calculated using the Kaplan–Meier method.Results: The histopathological diagnosis was Kaposi sarcoma in 20.5 per cent of cases, chondrosarcoma in 15.3 per cent and osteosarcoma in 10.2 per cent. A range of other sarcomas were diagnosed in the remaining patients. The site of disease was most commonly sinonasal, followed by the oral cavity and larynx.Conclusion: Wide local excision with clear resection margins is essential to achieve local control and long-term survival. There is a need for cross-specialty collaboration in order to accrue the evidence which will be necessary to improve long-term outcomes.

3 November 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
MSMarios Stavrakas
Marios Stavrakas
PKPetros D. Karkos
Petros D. Karkos
ZTZinovia Tsinaslanidou
Zinovia Tsinaslanidou
JCJannis Constantinidis
Jannis Constantinidis

18 August 2020 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
KLKimberley Lau
Kimberley Lau
MSMarios Stavrakas
Marios Stavrakas
MYMark Yardley
Mark Yardley
JRJaydip Ray
Jaydip Ray
Objectives: The mainstay of cholesteatoma treatment is surgical and requires the removal of all squamous epithelium from the underlying normal structure. The application of laser technology in middle ear and mastoid surgery has shown promise in achieving both disease eradication and hearing preservation. This systematic review aims to include studies that have assessed the application of laser to the treatment of cholesteatoma and to review its outcomes in terms of disease eradication as well as hearing results. Method: Two independent researchers conducted a systematic review of the literature on MEDLINE and Cochrane library, according to PRISMA guidance. Result: The search resulted in 12 papers, reporting on 536 participants that fulfilled the inclusion criteria. The hearing results did not show that using laser surgery improved hearing in cholesteatoma surgery, but neither has the use of laser shown to deteriorate hearing. With regards to the prevention of residual/recurrent cholesteatoma, the current literature reports a residual/recurrent rate of 0% to 33%. The complication rate of facial palsy is 0.6%. Conclusion: While there is certainly a role for future studies especially randomised large-cohort prospective comparative studies, the current literature suggests that laser may have a role in prevention or minimizing of residual cholesteatoma and generally have a safe hearing outcome profile.

12 June 2020 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
PKPetros D. Karkos
Petros D. Karkos
IKIoannis Koskinas
Ioannis Koskinas
MSMarios Stavrakas
Marios Stavrakas
STStefanos Triaridis
Stefanos Triaridis
JCJannis Constantinidis
Jannis Constantinidis
Lasers have been used in otolaryngology for more than 40 years and are widely considered an established way of addressing laryngeal pathology, benign and malignant. Carbon dioxide (CO2) laser is considered a gold standard, but over the last 2 decades, a new technology has been developed and established in other medical specialties, not so much in Ear Nose and Throat (ENT), the diode laser. It consists of a flexible fiber that passes through a hollow guidance system and is capable of reaching certain angled spots easier than straight beam systems. Portability, lower cost, easier setup, and improved photocoagulation are just some of the many features rendering it an excellent choice for the surgeon and the patient. The few studies published worldwide for the usage and efficacy of this system show no major differences related to the oncologic outcome and survival rate of patients having an early glottic tumor between diode laser microsurgery and CO2 laser cordectomy. Nevertheless, the advantages offered by fiber-optic laser surgery render it a worthy and perhaps equal alternative for treating this kind of pathology.

24 April 2021 in Indian Journal of Otolaryngology and Head & Neck Surgery
Verified
Journal Article
Closed access
PDF file
KVKonstantinos Vlachtsis
Konstantinos Vlachtsis
NTNikolaos Tsetsos
Nikolaos Tsetsos
SSSotiria Sotiroudi
Sotiria Sotiroudi
MSMarios Stavrakas
Marios Stavrakas
GFGeorgios Fyrmpas
Georgios Fyrmpas
ANAngelos Nikolaou
Angelos Nikolaou